William Demant Holding AS

Smorum, Denmarkwww.demant.com/
Invested through
  • Triodos Global Equities Impact Fund
  • Triodos Impact Mixed Fund - Defensive
  • Triodos Impact Mixed Fund - Neutral
  • Triodos Impact Mixed Fund - Offensive
Asset ClassesListed equity
Impact strategyImpact Equities and Bonds
Bloomberg tickerDEMANT DC
ISIN codeDK0060738599
Industry groupHealth Care Equipment & Services
Aligned with SDGs
  • Good health and well-being

Demant Group is a Danish hearing healthcare and technology company founded in 1904. The company develops, manufactures and sell products and equipment that help people with hearing loss connect and communicate with the world around them. Its main products include hearing devices, implants, diagnostic instruments, and personal communication equipment.

The company operates through two business segments: Hearing (hearing aid, care, implants, and diagnostics) and Communication (headsets), and is active in 130 countries.

Investment rationale

A 2018 WHO estimate suggests that approximately 466 million people (or 6.1% of the world’s population) have to live with a disabling hearing loss. This number is projected to rise to 630 million by 2030 and to over 900 million by 2050. Furthermore, the economic impact of unaddressed hearing loss on health, education and productivity for society is estimated to be over USD 750 billion globally.

As one of the leading hearing aid manufacturers, Demant brings significant solutions to the mentioned problems. Additionally, and among other things, the company's hearing care business strives to provide its customers with personalised care, licensed hearing care expertise, and life-changing hearing solutions. Around 90% of the company's revenue is directed to positive impact generated by the company's activities focused on finding solutions to help people with hearing loss.